These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9655703)

  • 21. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.
    Holm BA; Enhorning G; Notter RH
    Chem Phys Lipids; 1988 Nov; 49(1-2):49-55. PubMed ID: 3233711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy.
    Whitsett JA; Ohning BL; Ross G; Meuth J; Weaver T; Holm BA; Shapiro DL; Notter RH
    Pediatr Res; 1986 May; 20(5):460-7. PubMed ID: 3754957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in subphase aggregates in rabbits injured by free fatty acid.
    Hall SB; Hyde RW; Notter RH
    Am J Respir Crit Care Med; 1994 May; 149(5):1099-106. PubMed ID: 8173747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of surfactant function by copper-zinc superoxide dismutase (CuZn-SOD).
    Haddad IY; Nieves-Cruz B; Matalon S
    J Appl Physiol (1985); 1997 Nov; 83(5):1545-50. PubMed ID: 9375318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonionic polymers reverse inactivation of surfactant by meconium and other substances.
    William Taeusch H; Lu KW; Goerke J; Clements JA
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1391-5. PubMed ID: 10228100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding.
    Kim YL; Im YJ; Ha NC; Im DS
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):130-8. PubMed ID: 17259079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant.
    Schram V; Hall SB
    Biophys J; 2001 Sep; 81(3):1536-46. PubMed ID: 11509366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentration-dependent, temperature-dependent non-Newtonian viscosity of lung surfactant dispersions.
    King DM; Wang Z; Kendig JW; Palmer HJ; Holm BA; Notter RH
    Chem Phys Lipids; 2001 Jul; 112(1):11-9. PubMed ID: 11518568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface properties after a simulated PLA2 hydrolysis of pulmonary surfactant's main component, DPPC.
    Lema G; Enhorning G
    Biochim Biophys Acta; 1997 Mar; 1345(1):86-92. PubMed ID: 9084505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
    Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
    Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
    Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
    Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An X-ray diffraction study of alterations in bovine lung surfactant bilayer structures induced by albumin.
    Larsson M; Nylander T; Keough KM; Nag K
    Chem Phys Lipids; 2006; 144(2):137-45. PubMed ID: 17055468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pivotal role of anionic phospholipids in determining dynamic behavior of lung surfactant.
    Ingenito EP; Mora R; Mark L
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):831-8. PubMed ID: 10712330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of pulmonary surfactant by oleic acid: mechanisms and characteristics.
    Hall SB; Lu RZ; Venkitaraman AR; Hyde RW; Notter RH
    J Appl Physiol (1985); 1992 May; 72(5):1708-16. PubMed ID: 1601776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between hematological derivatives and dipalmitoyl phosphatidyl choline: implications for adult respiratory distress syndrome.
    Banerjee RR
    Colloids Surf B Biointerfaces; 2004 Mar; 34(2):95-104. PubMed ID: 15261079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.